- Accueil
- 98 054 508 ds
- G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
5 (167) · € 30.50 · En Stock
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
Deciphering G-Protein-Coupled Receptor 119 Agonists as Promising Strategy against Type 2 Diabetes Using Systems Biology Approach
Targeting GPCRs Activated by Fatty Acid-Derived Lipids in Type 2 Diabetes: Trends in Molecular Medicine
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. - Abstract - Europe PMC
Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119 - ScienceDirect
IJMS, Free Full-Text
GPR119 cell line G-protein coupled receptor 119 (GPR119) Cell Line-XP_066873.1
GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy, Journal of Experimental & Clinical Cancer Research
PDF) First GPR119 PET Imaging Ligand: Synthesis, Radiochemistry, and Preliminary Evaluations
GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus - ScienceDirect
Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. - Abstract - Europe PMC
Exploring the recent molecular targets for diabetes and associated complications
Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. - Abstract - Europe PMC
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes - ScienceDirect
